MicroRNA MiR-17 retards tissue growth and represses fibronectin expression

Nature Cell Biology

Volumn 11, Issue 8, 2009, Pages 1031-1038

  Shan, Sze Wan ^a,d   Lee, Daniel Y ^a,d   Deng, Zhaoqun ^a   Shatseva, Tatiana ^a   Jeyapalan, Zina ^a,d   Du, William W ^a   Zhang, Yaou ^b   Xuan, Jim W ^c   Yee, Siu Pok ^c,e   Siragam, Vinayakumar ^a   Yang, Burton B ^a,d  

^a Sunnybrook Health Sciences Centre   (Canada)

^b Shenzhen Graduate School   (China)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; FIBRONECTIN; FIBRONECTIN TYPE III DOMAIN CONTAINING 3A; IMMUNOGLOBULIN M; MEMBRANE PROTEIN; MICRORNA; MICRORNA MIR 17; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENOTYPE; GROWTH RETARDATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LYMPH NODE; LYMPHOPOIESIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; TISSUE DISTRIBUTION; TISSUE GROWTH; TRANSGENE;

ANIMALS; BASE SEQUENCE; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FIBRONECTINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MICRORNAS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPLEEN; TRANSFECTION;

MUS MUSCULUS;

EID: 68249126627     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1917     Document Type: Article

References (38)

1. Lim, L. P., Glasner, M. E., Yekta, S., Burge, C. B. & Bartel, D. P. Vertebrate microRNA genes. Science 299, 1540 (2003).
2. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419 (2003).
3. Ota, A. et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087-3095 (2004).
4. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005).
5. Hayashita, Y. et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628-9632 (2005).
6. Landais, S., Landry, S., Legault, P. & Rassart, E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res. 67, 5699-5707 (2007).
7. Petrocca, F. et al. E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13, 272-286 (2008).
8. Koralov, S. B. et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132, 860-874 (2008).
9. Sylvestre, Y. et al. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 282, 2135-2143 (2007).
10. Mendell, J. T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133, 217-222 (2008).
11. O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843 (2005).
12. Dews, M. et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genet. 38, 1060-1065 (2006).
13. Zhang, L. et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA 103, 9136-9141 (2006).
14. Ivanovska, I. et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell Biol. 28 2167-2174 (2008).
15. Lu, Y., Thomson, J. M., Wong, H. Y., Hammond, S. M. & Hogan, B. L. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 310, 442-453 (2007).
16. Matsubara, H. et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26, 6099-6105 (2007).
17. Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875-886 (2008).
18. Xiao, C. et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunol. 9, 405-414 (2008).
19. Fontana, L. et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nature Cell Biol. 9, 775-787 (2007).
20. Ye, W. et al. The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS ONE 3 e1719 (2008).
21. Wang, C. H. et al. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS ONE 3, e2420 (2008).
22. Hossain, A., Kuo, M. T. & Saunders, G. F. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell Biol. 26, 8191-8201 (2006).
23. Wang, Q. et al. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc. Natl Acad. Sci. USA 105, 2889-2894 (2008).
24. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol. (2008).
25. Rybak, A. et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nature Cell Biol. 10, 987-993 (2008).
26. Naguibneva, I. et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nature Cell Biol. 8, 278-284 (2006).
27. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129 (2008).
28. Jiang, G., Giannone, G., Critchley, D. R., Fukumoto, E. & Sheetz, M. P. Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin. Nature 424, 334-337 (2003).
29. Rifes, P. et al. Redefining the role of ectoderm in somitogenesis: a player in the formation of the fibronectin matrix of presomitic mesoderm. Development 134, 3155-3165 (2007).
30. Karaulanov, E. E., Bottcher, R. T. & Niehrs, C. A role for fibronectin-leucine-rich transmembrane cell-surface proteins in homotypic cell adhesion. EMBO Rep. 7, 283-290 (2006).
31. Georges-Labouesse, E. N., George, E. L., Rayburn, H. & Hynes, R. O. Mesodermal development in mouse embryos mutant for fibronectin. Dev. Dyn. 207, 145-156 (1996).
32. Lee, D. Y., Deng, Z., Wang, C. H. & Yang, B. B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl Acad. Sci. USA 104, 20350-20355 (2007).
33. Lee, D. Y. et al. A 3′-untranslated region (3′UTR) induces organ adhesion by regulating miR-199a* functions. PLoS ONE 4, e4527 (2009).
34. Sheng, W. et al. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol. Biol. Cell 16, 1330-1340 (2005).
35. Sheng, W. et al. Versican mediates mesenchymal-epithelial transition. Mol. Biol. Cell 17, 2009-2020 (2006).
36. Yee, A. J. et al. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res. 9 R47 (2007).
37. LaPierre, D. P. et al. The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res. 67, 4742-4750 (2007).
38. Hua, Z. et al. MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia. PLoS ONE 1, e116 (2006).